Masimo (NASDAQ:MASI) is a global medical technology company specializing in innovative noninvasive monitoring solutions. Headquartered in Irvine, California, Masimo develops and manufactures advanced patient monitoring systems that measure oxygen saturation, pulse rate, and other vital signs using proprietary signal processing technologies. Its flagship product, Masimo SET® (Signal Extraction Technology), has become widely adopted in hospitals and clinics worldwide for its ability to provide accurate readings in challenging clinical conditions such as patient motion or low perfusion.
Since its founding in 1989 by CEO and Chairman Joe Kiani, Masimo has expanded its product portfolio to include rainbow® Pulse CO-Oximetry, which noninvasively measures multiple blood constituents, and SedLine® brain function monitoring for guiding anesthesia and sedation. The company also offers cerebral oximetry devices for monitoring regional oxygen saturation in the brain, acoustic monitoring solutions for respiration rate, and connectivity platforms that integrate data across hospital networks. Masimo’s technologies are designed to improve patient outcomes, reduce the risk of complications, and enhance clinical workflow efficiency.
Masimo’s products are sold in more than 100 countries through a direct sales force and a network of distributors. In addition to its Irvine headquarters, the company maintains regional offices and manufacturing facilities in Europe, Asia, and Latin America. Masimo has pursued strategic acquisitions to complement its core monitoring capabilities, expand its presence in new markets, and accelerate innovation in areas such as consumer health and wearable sensors.
Under the leadership of Joe Kiani and a management team with extensive experience in medical devices and healthcare technology, Masimo continues to invest in research and development to advance noninvasive monitoring. The company’s commitment to patient safety and its track record of delivering clinical evidence have helped establish Masimo as a recognized leader in the global patient monitoring market.
